[Pain assessment during medical abortion up to 14 weeks: A 1-year prospective comparative study]

Gynecol Obstet Fertil Senol. 2023 Nov-Dec;51(11-12):511-516. doi: 10.1016/j.gofs.2023.07.007. Epub 2023 Aug 18.
[Article in French]

Abstract

Objectives: Pain assessment of patients requesting a medical abortion according to the term, up to 14 weeks, by a numerical rating scale (NRS).

Methods: This was a single-centre prospective observational study conducted at the University Hospitals of Strasbourg from 1st October 2019 to 31st December 2020.

Results: There was no significant difference in pain assessed by the NRS for medical abortion performed between 7-9 weeks and those performed between 9-14 weeks (6.5±2.5 vs. 6.6±2.2, P=0.85). Regardless of the term (before 7 weeks, between 7-9 weeks and between 9-14 weeks), patients felt relieved by taking painkillers in the case of medical abortion in 88.9%, 80.3% and 87.3% of cases respectively (P=0.18). The use of analgesics allowed a decrease of 3 points of the NRS in the 3 groups (P=0.67). Patients were more painful in case of medical protocol vs. surgical (maximum pain at 6.0±2.6 vs. 1.4±2.0, P<0.01), but declared to be relieved by analgesics in 85.1 and 94.3% of cases (P=0.24).

Conclusions: As pain is similar whatever the term in the case of medical abortion, and its management by analgesics seems to be effective, this criterion should not guide the professional in the choice of method, particularly between 9 and 14 weeks. This choice must be made by the patient.

Keywords: Analgesics; Antalgiques; Douleurs; Gynecology; Gynécologie; IVG chirurgicale; IVG médicamenteuse; Medical abortion; Pain; Surgical abortion.

Publication types

  • Observational Study
  • English Abstract

MeSH terms

  • Abortion, Induced*
  • Analgesics / therapeutic use
  • Female
  • Humans
  • Pain / drug therapy
  • Pain / etiology
  • Pain Measurement
  • Pregnancy
  • Prospective Studies

Substances

  • Analgesics